First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes

NCT05022030 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Colo-rectal Cancer
Capecitabine
Cetuximab

Interventions

DRUG: mCapOX plus cetuximab
DRUG: mFOLFOX6 plus cetuximab

Sponsor

West China Hospital

Collaborators

[object Object]